Search - tctmd.com

Displaying 561 - 580 of 1685

Sort: Relevancy | Date

News Daily News

Air Pollution, Whether Outdoor or Indoor, Ups Death Risk

Caitlin E. Cox

June 27, 2022

News Daily News

No Increased MACE Following COVID-19 Vaccination in Adults With CVD

Yael L. Maxwell

June 24, 2022

News

LGBTQ+ People at Risk of Worse CV Health, Subpar Care: AHA

Caitlin E. Cox

June 24, 2022

News Daily News

FDA Plans to Slash Nicotine Levels in Cigarettes and Other Products

Michael O'Riordan

June 23, 2022

News Daily News

USPSTF: Most Vitamin, Supplement Data Still ‘Inconclusive’ on CVD Benefits

Yael L. Maxwell

June 23, 2022

News Features

Climate Cardiology: If Not Now, When?

Caitlin E. Cox

June 20, 2022

News Daily News

Too Much Sitting Linked to Bad Outcomes Around the Globe: PURE

Michael O'Riordan

June 17, 2022

News Daily News

Research Clarifies Link Between BP Problems in Pregnancy and Later CVD

Yael L. Maxwell

June 13, 2022

News Daily News

Short-term Testosterone Use Doesn’t Spur CV Events: Meta-analysis

Caitlin E. Cox

June 10, 2022

News Daily News

Reassuring Data—and Some Lessons—From Pregnancy-Related SCAD Registry

Caitlin E. Cox

June 08, 2022

News Daily News

Heart Failure Risks of Smoking Can Linger for Decades

L.A. McKeown

June 07, 2022

News Daily News

Omega-3 Fatty Acids Linked to BP Reductions, Meta-analysis Hints

L.A. McKeown

June 06, 2022

News Opinion CV Team Dispatch

June 2022 News Roundup

L.A. McKeown

June 01, 2022

News Daily News

Social Factors Contribute to Race Differences in Premature CVD: CARDIA

Yael L. Maxwell

May 30, 2022

News Conference News EAS 2022

Most Kids With FH Diagnosed by Cascade Screening, Albeit Late and Ineffectively

Michael O'Riordan

May 27, 2022

News Conference News EAS 2022

Elevated Risks From Lp(a) Can Be Offset by Lower Lifetime LDL Cholesterol

Michael O'Riordan

May 26, 2022

News Conference News EAS 2022

FH Patients Face Unchanging Acute MI Risks Plus Very Late Diagnoses

Michael O'Riordan

May 26, 2022

News Conference News EAS 2022

ROSE Trial: CETP Inhibitor Shows Promise as Oral Add-on for LDL-Lowering

Michael O'Riordan

May 24, 2022

News Conference News EAS 2022

Stepwise or Hammer Down? Experts Debate Best Approach to LDL-Lowering

Michael O'Riordan

May 24, 2022

News Conference News ESC Heart Failure 2022

Dapagliflozin Boosts Health Status Across LVEF Range

Shelley Wood

May 23, 2022

Advertisement

Air Pollution, Whether Outdoor or Indoor, Ups Death Risk

No Increased MACE Following COVID-19 Vaccination in Adults With CVD

LGBTQ+ People at Risk of Worse CV Health, Subpar Care: AHA

FDA Plans to Slash Nicotine Levels in Cigarettes and Other Products

USPSTF: Most Vitamin, Supplement Data Still ‘Inconclusive’ on CVD Benefits

Climate Cardiology: If Not Now, When?

Too Much Sitting Linked to Bad Outcomes Around the Globe: PURE

Research Clarifies Link Between BP Problems in Pregnancy and Later CVD

Short-term Testosterone Use Doesn’t Spur CV Events: Meta-analysis

Reassuring Data—and Some Lessons—From Pregnancy-Related SCAD Registry

Heart Failure Risks of Smoking Can Linger for Decades

Omega-3 Fatty Acids Linked to BP Reductions, Meta-analysis Hints

June 2022 News Roundup

Social Factors Contribute to Race Differences in Premature CVD: CARDIA

Most Kids With FH Diagnosed by Cascade Screening, Albeit Late and Ineffectively

Elevated Risks From Lp(a) Can Be Offset by Lower Lifetime LDL Cholesterol

FH Patients Face Unchanging Acute MI Risks Plus Very Late Diagnoses

ROSE Trial: CETP Inhibitor Shows Promise as Oral Add-on for LDL-Lowering

Stepwise or Hammer Down? Experts Debate Best Approach to LDL-Lowering

Dapagliflozin Boosts Health Status Across LVEF Range

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content